Indegene Limited
Indegene Limited (INDGN.BO) Stock Competitors & Peer Comparison
See (INDGN.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| INDGN.BO | ₹464.85 | +2.87% | 104.4B | 23.86 | ₹18.21 | +0.46% |
| IKS.NS | ₹1,331.50 | -1.72% | 222.5B | 34.13 | ₹38.92 | N/A |
| IKS.BO | ₹1,335.10 | -1.28% | 222.5B | 34.10 | ₹38.95 | N/A |
| SAGILITY.NS | ₹41.71 | -0.10% | 187B | 22.07 | ₹1.81 | +0.13% |
| SAGILITY.BO | ₹41.72 | +0.00% | 187B | 22.07 | ₹1.81 | +0.13% |
| INDGN.NS | ₹464.55 | +2.75% | 104.4B | 23.85 | ₹18.22 | +0.46% |
Stock Comparison
INDGN.BO vs IKS.NS Comparison April 2026
INDGN.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDGN.BO stands at 104.4B. In comparison, IKS.NS has a market cap of 222.5B. Regarding current trading prices, INDGN.BO is priced at ₹464.85, while IKS.NS trades at ₹1,331.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDGN.BO currently has a P/E ratio of 23.86, whereas IKS.NS's P/E ratio is 34.13. In terms of profitability, INDGN.BO's ROE is +0.17%, compared to IKS.NS's ROE of +0.37%. Regarding short-term risk, INDGN.BO is more volatile compared to IKS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for INDGN.BO.Check IKS.NS's competition here